🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Our study included 60 patients with idiopathic OAB and treated with solifen...
Status
Completed
Location
Beni-Suef University
Start Date
2018-01-01
Trial ID
NCT04064619
Treatments Being Tested
Women presenting with overactive bladder symptoms will be randomized to one...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2019-08-05
Trial ID
NCT03817931
This study will evaluate the treatment satisfaction, discontinuation, reaso...
Status
Completed
Location
Urology Centers of Alabama
Start Date
2021-10-28
Trial ID
NCT05067478
Treatments Being Tested
Botulinum toxin type A injections into the detrusor at a dose of 200 units ...
Status
Terminated
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2021-06-01
Trial ID
NCT04819360
Treatments Being Tested
The objective of this study is to evaluate change of Overactive Bladder (OA...
Status
Completed
Location
Site: 1
Start Date
2009-09
Trial ID
NCT02667470
Treatments Being Tested
To investigates the effects of solifenacin or mirabegron with local estroge...
Status
Recruiting
Location
Mackay Memorial Hospital
Start Date
2022-06-16
Trial ID
NCT06479720
This study will be conducted to compare the effectiveness of alpha blocker ...
Status
Completed
Location
Urology and Nephrology Center
Start Date
2013-01
Trial ID
NCT01880619
Treatments Being Tested
To evaluate the effect of controlling lower urinary tract symptoms (LUTS) w...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT02845648
Treatments Being Tested
This study evaluated the outcomes of women with detrusor overactivity treat...
Status
Completed
Location
Mackay Memorial Hospital
Start Date
2022-06-01
Trial ID
NCT07337252
Treatments Being Tested
A randomized clinical study to evaluate the safety and efficacy of using th...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02
Trial ID
NCT05240456
Treatments Being Tested